VIM and non-small cell lung carcinoma: Consistently, western blotting revealed that TGFβ1 treatment enhanced Vimentin and reduced E-cadherin protein expression only in TGFβ1 sensitive NSCLC cells but not in TGFβ1 insensitive NSCLC cells (Fig 1D).